Prevenotics-G Pro’s core technology includes comprehensive AI real-time diagnostics from pre-cancerous stages to cancer, and a personalized multi-modal AI surveillance system (e.g., combining vision AI with generative natural language processing technology) for optimal preventive management. Currently undergoing clinical validation in major Korean hospitals, Prevenotics-G Pro is supported by secured and pending patents (PCT number: PCT/KR2023/019632; domestic registration: 10-2023-0011468; applications: 10-2022-0030995, 10-2022-0031951, 10-2023-0011469, 10-2023-0011470, 10-2023-0139629). Continuous medical research by top-level experts in gastric cancer prevention and endoscopy is advancing this groundbreaking solution in gastric cancer prevention